SAMIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings
Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 최대주주등소유주식변동신고서 | 2026-05-22 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-22 | Korean | |
| 최대주주등소유주식변동신고서 | 2026-05-20 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | |
| 최대주주등소유주식변동신고서 | 2026-05-06 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46781189 | 최대주주등소유주식변동신고서 | 2026-05-22 | Korean | ||
| 46760443 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-22 | Korean | ||
| 46576634 | 최대주주등소유주식변동신고서 | 2026-05-20 | Korean | ||
| 46365270 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 41786825 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | ||
| 41760333 | 최대주주등소유주식변동신고서 | 2026-05-06 | Korean | ||
| 39070405 | 최대주주등소유주식변동신고서 | 2026-04-30 | Korean | ||
| 35655181 | 주식등의대량보유상황보고서(일반) | 2026-04-23 | Korean | ||
| 33058346 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-27 | Korean | ||
| 33044624 | 정기주주총회결과 | 2026-03-26 | Korean | ||
| 33044616 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-26 | Korean | ||
| 33038369 | 최대주주등소유주식변동신고서 | 2026-03-25 | Korean | ||
| 32973704 | 감사보고서제출 | 2026-03-18 | Korean | ||
| 32972857 | 사업보고서 (2025.12) | 2026-03-18 | Korean | ||
| 32953919 | 최대주주등소유주식변동신고서 | 2026-03-16 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
SAMIL PHARMACEUTICAL CO.,LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16326/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16326 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16326 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16326 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16326}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SAMIL PHARMACEUTICAL CO.,LTD (id: 16326)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.